Try our Advanced Search for more refined results

Expert Analysis

The 'Palmetto Put-Down' Endangers Drug Cos. Nationwide

Law360, New York (March 12, 2015, 11:12 AM EDT) -- On Feb. 25, 2015, nearly two years after argument, the South Carolina Supreme Court directed entry of a $136 million judgment against Janssen Pharmaceuticals Inc.[1] These civil penalties stemmed from a suit brought by the state's attorney general relating to Risperdal, Janssen's "atypical," or "second generation," anti-psychotic medication, which has been on the market since 1994. The court found Janssen's communications to doctors had a "tendency to deceive," even though there was no evidence that any doctor had been deceived or any patient harmed....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!